Drugs of Today 2012, 48(12): [removed]THOMSON REUTERS Copyright © 2012 Prous Science, S.A.U. or its licensors. All rights reserved. CCC: [removed]

First Page		Document Content
Date: 2014-03-03 08:45:38 Stem cells Transplantation medicine Graft-versus-host disease Hematopoietic stem cell transplantation Cell therapy Mesenchymal stem cell Transplant rejection Center for International Blood and Marrow Transplant Research Immunosuppressive drug Medicine Biology Health		Drugs of Today 2012, 48(12): [removed]THOMSON REUTERS Copyright © 2012 Prous Science, S.A.U. or its licensors. All rights reserved. CCC: [removed] Add to Reading List Source URL: mesoblast.com Download Document from Source Website File Size: 206,19 KB Share Document on Facebook

	AZATHIOPRINE / 6-MERCAPTOPURINE TREATMENT FOR IBD PATIENTS INFORMATION SHEET This information leaflet is designed to answer common questions patients ask about their medicine. Further information can be found in the in DocID: 1qAnH - View Document
	Microsoft PowerPoint - PhilNat-ClinImmunmodulation2016 handout [Kompatibilitätsmodus] DocID: 1ogX3 - View Document
	In renal transplant patients at high-immunologic risk • Rapamune and Cyclosporine Combination Therapy (for the first 12 months post-transplantation): One loading dose of up to 15 mg on day 1, followed by daily mainten DocID: 1lhSD - View Document
	Dermatology Issue 6 t 2008 Optimised Treatment in Atopic Dermatitis – An Update and Outlook Treatment success factors – what makes a difference? DocID: 1fL0g - View Document
	Malaria Journal BioMed Central Open Access DocID: 1aYXj - View Document